Nanosized calcium-silicate biomineralization system for acid-resistant tubule occlusion

Technology
Conceptual
University
Scouted & summarized by Halo AI

Seoul National University researchers have developed a nanosized calcium-silicate biomineralization system to treat dentin hypersensitivity. The material uses dicalcium and tricalcium silicate nanoparticles to form acid-resistant, hydroxyapatite-like crystals inside dentinal tubules. This process effectively occludes the tubules, blocks dentinal fluid flow, and significantly reduces dentin permeability, offering a durable alternative to conventional desensitizing treatments.

Overview

The nanosized calcium-silicate biomineralization system is a research-based dental treatment designed to address dentin hypersensitivity. Developed at Seoul National University, this technology utilizes experimental materials composed of dicalcium silicate (DCS) and tricalcium silicate (TCS) at the nanoscale. The system works by promoting a biomineralization reaction that forms stable, acid-resistant hydroxyapatite-like crystals within exposed dentinal tubules. By occluding these tubules and blocking dentinal fluid flow, the treatment effectively reduces dentin permeability, providing a potential therapeutic approach for alleviating the discomfort associated with dentin hypersensitivity.

Technical specifications
  • Composition: Uses a mixture of nanosized dicalcium silicate (DCS) and tricalcium silicate (TCS).
  • Mechanism: Facilitates the formation of intratubular hydroxyapatite-like crystals through biomineralization.
  • Performance: Densely fills dentinal tubules, with crystal formation observed at depths exceeding 50 micrometers from the dentin surface.
  • Durability: The resulting crystals are resistant to acid challenges, preventing the rapid dissolution often seen with other desensitizing agents exposed to saliva, food, or mechanical stimulation.
  • Effectiveness: Significantly reduces dentin permeability as measured by hydraulic conductance.
Technology readiness level

The technology is currently at TRL 3. It has undergone laboratory-based in vitro assessments, including scanning electron microscopy and permeability testing on extracted premolars, demonstrating its ability to form acid-resistant crystals and reduce dentin permeability. Further research and development are required before clinical application.

Generated Nov 11, 2026. Please verify key information.

About Seoul National University

Seoul National University is a comprehensive public research university serving a large student and faculty community in Korea’s capital, recognized for cross‑disciplinary depth and scale. Industry partners engage through an industry–academia cooperation office that streamlines sponsored research, NDAs and master agreements, plus shared core facilities and prototyping spaces across its Gwanak and medical campuses. Integration with a major teaching hospital system enables clinical translation, while the Seoul location places teams close to corporate headquarters, government R&D agencies and a vibrant startup ecosystem for rapid collaboration and scale‑up. Research is supported by competitive national funding from the National Research Foundation of Korea and ministries such as Science and ICT, Trade, Industry and Energy, and Health and Welfare; a dedicated technology transfer office manages IP, licensing and startup formation.

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.